Invested $6,000 in CSL shares 5 years ago? Here’s how much dividend income you’ve earned

Did you invest in CSL Limited (ASX: CSL) shares five years ago? If so, you’re likely pretty happy with your decision. The biotechnology giant’s stock has roared 89% higher in that time.

An investor buying $6,000 worth of CSL shares in April 2018 likely would have walked away with 37 stocks ­– paying $159.88 apiece – and approximately $85 change.

Today, those 37 shares would be worth a total of $11,180.66. The CSL share price last traded at $302.18.

For comparison, the S&P/ASX 200 Index (ASX: XJO) has lifted just 25% in that time.

Meanwhile, the healthcare staple has been paying out consistent dividends. Let’s take a look at how much passive income the figurative holding might have yielded over its life.

All dividends paid to those holding CSL shares since 2018

Here are all the dividends paid to those invested in CSL stock over the last five years, rounded to the nearest cent:

As readers can see, each CSL share has yielded $14.61 in dividends over the last five years.

That means our figurative parcel has likely provided $540.57 of passive income over its lifetime – bringing our total return on investment (ROI) to an impressive 98%.

And that’s before considering the compounding returns that could have been realised if one had reinvested their dividends.

Not to mention, some of the ASX 200 biotech’s dividends in that time were partially franked. Thus, they may have brought additional benefits come tax time.

Right now, CSL shares offer a 1.1% dividend yield.

The post Invested $6,000 in CSL shares 5 years ago? Here’s how much dividend income you’ve earned appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Morgans says these are among the best blue chip ASX 200 shares you can buy
• If I’d invested $1,000 in CSL shares 24 years ago, here’s how much I’d have now!
• Why did the CSL share price lag the ASX 200 in the first quarter of 2023?
• Build your portfolio around these ASX 200 blue chip shares: brokers
• Top defensive ASX shares to buy in April 2023

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/BSQbkeA